Knight Jeff E.'s Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Mar 18, 2026
- Accession no.
- 0001628280-26-019503
- Filed
- Mar 18, 2026
- Trade date
- Mar 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $370.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knight Jeff E.CIK 0001881007 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | SSaleDisposed | −5,950 | $37.11 | −$220,804.5 | 115,979 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −3,961 | $37.77 | −$149,606.97 | 112,018 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.